George Kaiser Family Foundation Buys Shares of 3,167,322 Aspen Aerogels, Inc. $ASPN

Key Points

• George Kaiser Family Foundation acquired 3.17 million Aspen Aerogels shares worth approximately $20.1 million, giving it a 3.82% stake and making ASPN its sixth-largest holding.
• Institutional ownership is substantial at 97.64%, with BlackRock, Oaktop Capital, Invesco and other investors also increasing or initiating positions during recent quarters.
• Analyst sentiment remains mixed: ASPN has an average “Hold” rating and a $5.94 price target. The company beat quarterly revenue and EPS expectations, but remains unprofitable, reporting a negative net margin of 62.45%.

George Kaiser Family Foundation purchased a new stake in Aspen Aerogels, Inc. (NYSE:ASPN - Free Report) in the second quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm purchased 3,167,322 shares of the construction company's stock, valued at approximately $20,081,000. Aspen Aerogels makes up 1.9% of George Kaiser Family Foundation's holdings, making the stock its 6th biggest position. George Kaiser Family Foundation owned 3.82% of Aspen Aerogels at the end of the most recent quarter.

Other hedge funds and other institutional investors have also made changes to their positions in the company. BlackRock Inc. purchased a new stake in shares of Aspen Aerogels in the 2nd quarter worth about $33,457,000. Oaktop Capital Management II L.P. purchased a new position in Aspen Aerogels during the 2nd quarter valued at about $32,769,000. Invesco Ltd. raised its position in Aspen Aerogels by 237.9% during the fourth quarter. Invesco Ltd. now owns 4,129,934 shares of the construction company's stock worth $11,688,000 after acquiring an additional 2,907,558 shares during the last quarter. Rice Hall James & Associates LLC acquired a new position in Aspen Aerogels during the second quarter worth about $10,368,000. Finally, Needham Investment Management LLC raised its position in Aspen Aerogels by 26.5% during the fourth quarter. Needham Investment Management LLC now owns 4,351,700 shares of the construction company's stock worth $12,315,000 after acquiring an additional 912,000 shares during the last quarter. Institutional investors and hedge funds own 97.64% of the company's stock.

Analysts Set New Price Targets

ASPN has been the topic of several research reports. Roth Capital reiterated a "buy" rating and issued a $7.75 price target on shares of Aspen Aerogels in a research report on Friday, August 7th. Weiss Ratings restated a "sell (d-)" rating on shares of Aspen Aerogels in a research report on Wednesday, June 24th. Barclays lifted their price objective on Aspen Aerogels from $4.00 to $5.00 and gave the stock an "underweight" rating in a research report on Tuesday, August 11th. B. Riley Financial reaffirmed a "buy" rating on shares of Aspen Aerogels in a research note on Friday, August 7th. Finally, Wall Street Zen downgraded Aspen Aerogels from a "hold" rating to a "sell" rating in a research report on Saturday, August 15th. Four equities research analysts have rated the stock with a Buy rating, one has given a Hold rating and two have issued a Sell rating to the company's stock. Based on data from MarketBeat, the stock has an average rating of "Hold" and an average price target of $5.94.

Aspen Aerogels Price Performance

NYSE:ASPN opened at $5.21 on Friday. The firm has a market cap of $432.38 million, a price-to-earnings ratio of -3.41 and a beta of 2.99. The company has a current ratio of 2.52, a quick ratio of 2.24 and a debt-to-equity ratio of 0.36. The company's 50-day moving average is $5.50 and its two-hundred day moving average is $4.58. Aspen Aerogels, Inc. has a 12-month low of $2.30 and a 12-month high of $9.35.

Aspen Aerogels (NYSE:ASPN - Get Free Report) last released its quarterly earnings results on Thursday, August 6th. The construction company reported ($0.22) earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.23) by $0.01. The company had revenue of $49.85 million for the quarter, compared to analysts' expectations of $42.42 million. Aspen Aerogels had a negative net margin of 62.45% and a negative return on equity of 31.12%. Aspen Aerogels has set its Q3 2026 guidance at -0.110--0.070 EPS. Research analysts expect that Aspen Aerogels, Inc. will post -0.69 EPS for the current year.

About Aspen Aerogels

Aspen Aerogels, Inc, headquartered in Northborough, Massachusetts, develops and manufactures high-performance aerogel insulation materials and custom engineered solutions. Founded in 2001 as a spin-out from Department of Energy research, the company pursued an initial public offering on the NYSE in 2014 under the ticker ASPN. Aspen Aerogels combines proprietary aerogel formulations with advanced manufacturing processes to deliver products known for their low thermal conductivity, lightweight construction and robust mechanical properties.

The company's product portfolio spans blanket insulation, boards, and custom shapes built around several proprietary brands, including Pyrogel, Cryogel and Spaceloft.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat

Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Add As Preferred Source